Enlivex R&D Spending Growth & History (ENLV)

Enlivex's r&d spending was $9.2M for fiscal 2025.

View full Enlivex company overview

Enlivex annual r&d spending history

Enlivex annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$9.2M−$1.4M−13.36%
20242024-12-31$10.6M−$8.4M−44.12%
20232023-12-31$19.0M$319,000+1.71%
20222022-12-31$18.7M$5.8M+45.12%
20212021-12-31$12.9M$6.8M+111.65%
20202020-12-31$6.1M$482,000+8.60%
20192019-12-31$5.6M$1.6M+39.65%
20182018-12-31$4.0M$2.3M+137.32%
20172017-12-31$1.7M−$7.2M−80.96%
20162016-12-31$8.9M$1.2M+15.43%
20152015-12-31$7.7M$3.3M+73.25%
20142014-12-31$4.4M$3.7M+506.69%
20132013-12-31$732,000$592,000+422.86%
20122012-12-31$140,000

Enlivex r&d spending trends

Over the last five fiscal years, Enlivex's r&d spending increased from $6.1M to $9.2M, a change of $3.1M. The latest reported quarter, Q4 2025, shows $3.0M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Enlivex source filings ↗

Community posts

It’s quiet here.

No posts about ENLV yet. Start the conversation.

Write the first post